The last ten years in the Pharma industry have been a nexus of change, as themes such as patient centricity, real-world data and integrated health regularly emerge and revolutionise the industry. It’s never been more important to keep up with the latest and most innovative thinking being developed across the globe.
We in the Life Sciences team at PEN got tired of waiting for a good publication that summarised these trends, so we decided to make one ourselves. To help you keep up to date, we have created Second Opinion, a regular round-up of the headlines that have caught our eye from across the Pharma industry.
This newsletter will provide you with a quick summary of what topics are leading conversations at an industry level, why you should care, and even some of our thoughts on what's important within the Pharma sector right now.
Stay in the know and sign up to our monthly newsletter Second Opinion using the form below. And while you're there, if it's of interest, why not sign up to our monthly Banking newsletter too.
